Lung microbiota and COVID-19 severity

Nat Microbiol. 2021 Oct;6(10):1217-1218. doi: 10.1038/s41564-021-00969-x.

Author

Robert P Dickson^{1

2

3}

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA. rodickso@med.umich.edu.
² Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA. rodickso@med.umich.edu.
³ Michigan Center for Integrative Research in Critical Care, Ann Arbor, MI, USA. rodickso@med.umich.edu.

PMID: 34580441
DOI: 10.1038/s41564-021-00969-x

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Bronchoscopy
COVID-19 / immunology
COVID-19 / microbiology
COVID-19 / pathology*
COVID-19 / virology
Critical Illness
Humans
Lung / immunology
Lung / microbiology*
Lung / pathology
Lung / virology
Microbiota*
Prognosis
SARS-CoV-2 / immunology
SARS-CoV-2 / pathogenicity*
Viral Load

Grants and funding